GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline: Part 2

At the conclusion of this activity, participants will be able to: 1. Review the evidence and outcomes on the treatment of M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced, Metastatic and CRPC guidelines. 2. Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urological practice This educational series is supported by independent educational grants from: • Astellas • AstraZeneca • Bristol Myers Squibb • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC • Merck • Pfizer, Inc • Sanofi Genzyme • UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/30174